![]() |
Volumn 41, Issue 41, 2012, Pages 12766-12772
|
Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI-CANCER AGENTS;
ANTICANCER ACTIONS;
ANTICANCER DRUG;
BIOLOGICAL RECEPTORS;
CALF THYMUS DNA;
CANCER CELL APOPTOSIS;
CANCER CELLS;
CASPASE-3;
CELLULAR INTERNALIZATION;
CHEMOTHERAPEUTIC AGENTS;
DNA DAMAGES;
DNA INTERACTION;
DNA STRAND BREAK;
DOSE-DEPENDENT MANNER;
FLUORESCENCE INTENSITIES;
INTERCALATIVE BINDING;
POLY(ADP-RIBOSE) POLYMERASE;
PYRIDINE DERIVATIVES;
RUTHENIUM COMPLEXES;
SIGNALLING PATHWAYS;
UNDERLYING MECHANISM;
UV-VIS ABSORPTIONS;
CELL DEATH;
CHLORINE COMPOUNDS;
PHOSPHORYLATION;
PYRIDINE;
RUTHENIUM;
RUTHENIUM COMPOUNDS;
VISCOSITY MEASUREMENT;
DNA;
2,6 BIS(BENZIMIDAZOL 2 YL)PYRIDINE;
2,6-BIS(BENZIMIDAZOL-2-YL)PYRIDINE;
ANTINEOPLASTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
H2AFX PROTEIN, HUMAN;
HISTONE;
PROTEIN BCL 2;
PROTEIN P53;
PYRIDINE DERIVATIVE;
RUTHENIUM;
APOPTOSIS;
ARTICLE;
CHEMISTRY;
DNA DAMAGE;
DRUG EFFECT;
HUMAN;
METABOLISM;
NEOPLASM;
PHOSPHORYLATION;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BENZIMIDAZOLES;
CELL LINE, TUMOR;
DNA DAMAGE;
HISTONES;
HUMANS;
NEOPLASMS;
PHOSPHORYLATION;
PROTO-ONCOGENE PROTEINS C-BCL-2;
PYRIDINES;
RUTHENIUM;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 84867298249
PISSN: 14779226
EISSN: 14779234
Source Type: Journal
DOI: 10.1039/c2dt30665d Document Type: Article |
Times cited : (58)
|
References (47)
|